Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Various Advanced Cancer”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Early research (Phase 1)Study completedNCT01905111
What this trial is testing

BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 21
Testing effectiveness (Phase 2)WithdrawnNCT03704077
What this trial is testing

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerCancer of the StomachStomach Cancer+1 more
Bristol-Myers Squibb
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Not applicableUnknownNCT04831632
What this trial is testing

Diagnostic Performance Assessment of Qualitative Ifobt and Quantitative Ifobt for Advanced Neoplastic

Who this might be right for
Colorectal Neoplasms
CECILIA CURVALE 630
Large-scale testing (Phase 3)Study completedNCT03143153
What this trial is testing

Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 970
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05327530
What this trial is testing

The Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc. 256
Early research (Phase 1)UnknownNCT04849247
What this trial is testing

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

Who this might be right for
177Lu-DOTA-FAPI68Ga-DOTA-FAPITheranostic
The First Affiliated Hospital of Xiamen University 30
Early research (Phase 1)Study completedNCT01335269
What this trial is testing

BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 96
Testing effectiveness (Phase 2)Ended earlyNCT04913220
What this trial is testing

SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)

Who this might be right for
Malignant MelanomaSquamous Cell Carcinoma of Skin
Sanofi 46
Early research (Phase 1)Study completedNCT05372367
What this trial is testing

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Who this might be right for
Solid Tumors
Boehringer Ingelheim 33
Testing effectiveness (Phase 2)Study completedNCT02488759
What this trial is testing

An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 578
Early research (Phase 1)Study completedNCT01938846
What this trial is testing

BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05676931
What this trial is testing

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Gilead Sciences 400
Large-scale testing (Phase 3)Study completedNCT02632409
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 709
Testing effectiveness (Phase 2)Study completedNCT02387996
What this trial is testing

Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 270
Early research (Phase 1)Study completedNCT01096355
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 28
Early research (Phase 1)Ended earlyNCT01986218
What this trial is testing

Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Testing effectiveness (Phase 2)Looking for participantsNCT07558733
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

Who this might be right for
HR+ HER2- Breast Cancer
Faeth Therapeutics 32
Next Page